Peroxin-26: A Promising Drug Target and Biomarker (G55670)

Target Name: PEX26

NCBI ID: G55670

PEX26

Peroxin-26: A Promising Drug Target and Biomarker

Peroxin-26 (PEX26) is a peroxisome-dividing enzyme (PDZ) that is involved in various cellular processes. It is a 26 kDa protein that is expressed in various tissues, including the brain, heart, and liver. PEX26 functions as a critical regulator of the peroxidation process, which is a ubiquitous cellular pathway that involves the oxidation and reduction of reactive oxygen species (ROS).

PEX26 is a potential drug target due to its unique structure and its involvement in various cellular processes. Its unique peroxisome-dividing function makes it an attractive target for small molecules that can modulate its activity. Additionally, its expression in various tissues provides a promising biomarker for the diagnosis and treatment of various diseases.

The Discovery of PEX26

PEX26 was first identified as a protein that was expressed in the brain and was shown to be involved in the regulation of neurotransmitter synthesis and release. Subsequent studies have shown that PEX26 is involved in various cellular processes, including cell signaling, DNA replication, and metabolism.

One of the most significant findings is that PEX26 is involved in the peroxidation process. Peroxidation is the production of ROS, which can damage cellular components and contribute to various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The peroxidation process is critical for the survival of cells, and it is a complex pathway that involves various cellular components, includingPEX26 (6).PEX26 functions as a critical regulator of this process by catalyzing the oxidation and reduction of ROS, which are involved in the formation of peroxides.

In addition to its involvement in the peroxidation process, PEX26 has also been shown to be involved in various signaling pathways. It has been shown to be involved in the regulation of cell signaling, including the production of neurotransmitters and the modulation of protein kinase activity.

The Potential therapeutic Benefits of PEX26

The potential therapeutic benefits of PEX26 are vast and range from neurodegenerative diseases to cancer. Since PEX26 is involved in various cellular processes that are essential for the survival of cells, any molecules that can modulate its activity may have significant therapeutic potential.

One of the most promising therapeutic approaches for PEX26 is the use of small molecules as inhibitors. Since PEX26 is involved in various signaling pathways, small molecules that can modulate its activity may have significant therapeutic potential in a variety of diseases.

For example, PEX26 has been shown to be involved in the regulation of neurotransmitter synthesis and release, and small molecules that can modulate its activity may have significant therapeutic potential in the treatment of neurodegenerative diseases. Additionally, PEX26 has also been shown to be involved in the regulation of cell signaling, and small molecules that can modulate its activity may have significant therapeutic potential in the treatment of cancer.

Another promising therapeutic approach for PEX26 is the use of small molecules as modulators. Since PEX26 is involved in various cellular processes that are essential for the survival of cells, small molecules that can modulate its activity may have significant therapeutic potential in diseases that are characterized by the overproduction of ROS, such as cancer and neurodegenerative diseases.

Conclusion

PEX26 is a peroxisome-dividing enzyme that is involved in various cellular processes that are essential for the survival of cells. Its unique structure and its involvement in various cellular processes make it an attractive target for small molecules that can modulate its activity. Additionally, its expression in various tissues provides a promising biomarker for the diagnosis and treatment of various diseases.

The potential therapeutic benefits of PEX26 are vast and range from neurodegenerative diseases to cancer. Any molecules that can

Protein Name: Peroxisomal Biogenesis Factor 26

Functions: Peroxisomal docking factor that anchors PEX1 and PEX6 to peroxisome membranes (PubMed:12717447, PubMed:12851857, PubMed:16854980, PubMed:21362118, PubMed:16763195, PubMed:16257970). PEX26 is therefore required for the formation of the PEX1-PEX6 AAA ATPase complex, a complex that mediates the extraction of the PEX5 receptor from peroxisomal membrane (PubMed:12717447, PubMed:12851857, PubMed:16854980, PubMed:21362118, PubMed:16763195, PubMed:16257970)

The "PEX26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PEX26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets